Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210) Meeting Abstract
| Authors: | Rosenberg, J.; Petrylak, D.; Abidoye, O.; Van der Heijden, M. S.; Hofman-Censits, J.; Necchi, A.; O'Donnell, P. H.; Balmanoukian, A.; Loriot, Y.; Retz, M.; Perez-Gracia, J. L.; Dawson, N. A.; Balar, A.; Galsky, M. D.; Fleming, M. T.; Powles, T.; Cui, N.; Mariathasan, S.; Fine, G. D.; Dreicer, R. |
| Abstract Title: | Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210) |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S720 |
| Language: | English |
| ACCESSION: | WOS:000361887403272 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31942-6 |
| Notes: | Meeting Abstract: 21LBA -- Source: Wos |
